Chester County News and Community Website
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) has made strides in the fight against neurodegenerative diseases with the filing of three new patents. These cover novel combination therapies involving their …
Annovis Bio Files Patents for Innovative Therapies in Neurodegenerative Disease Treatment Read More
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) is set to present three pivotal clinical studies on its Barrigel™ rectal spacer at the American Society for Radiation Oncology (ASTRO) Annual Meeting, …
Teleflex to Showcase Barrigel Rectal Spacer Studies at ASTRO 2024 Read More
PHILADELPHIA, PA — The Wistar Institute has made a significant breakthrough in understanding the role of Parkin, a protein traditionally associated with Parkinson’s disease, in the body’s immune response to cancer. …
Wistar Institute Breakthrough: Parkin Protein Revealed as a Game-Changer in Cancer Immunity! Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has commenced its Phase 2a clinical trial for ATI-2138, an innovative oral covalent inhibitor targeting ITK and JAK3, aimed at treating moderate to …
Aclaris Therapeutics Launches Phase 2a Trial for ATI-2138 in Atopic Dermatitis Read More
MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has unveiled promising data from its Phase 2 clinical study of collagenase clostridium histolyticum (CCH) in treating plantar fibromatosis, presented at the American Orthopaedic …
Endo, Inc. Highlights Promising Study Results for Plantar Fibromatosis Treatment Read More
PHOENIXVILLE, PA — PleoPharma, Inc. has announced promising results from a Phase 2b study evaluating its leading drug candidate, PP-01, intended for mitigating Cannabis Withdrawal Syndrome. Conducted across 22 US addiction …
PleoPharma’s PP-01 Shows Promise in Treating Cannabis Withdrawal Syndrome Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has reached a significant milestone in its GARDian clinical trial for OCU410ST, a promising gene therapy aimed at treating Stargardt disease. The company …
Ocugen Advances Gene Therapy Trial for Stargardt Disease Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has received approval from Health Canada to begin the Phase 3 liMeliGhT clinical trial for their OCU400 gene therapy. This trial aims to …
Ocugen Expands Gene Therapy Trial to Canada Read More
WEST CHESTER, PA — Centinel Spine has unveiled encouraging data supporting the long-term success and market expansion of lumbar total disc replacement (LTDR). A pivotal study conducted by the Texas …
Centinel Spine Highlights Long-Term Success and Growth of Lumbar Disc Replacement Read More WAYNE, PA — Teleflex Incorporated (NYSE: TFX) recently announced the publication of a new retrospective analysis demonstrating the benefits of the Titan SGS™ Stapler in laparoscopic sleeve gastrectomy (LSG). Conducted by …
Teleflex Publishes New Study Highlighting Benefits of Titan SG Stapler in Laparoscopic Sleeve Gastrectomy Read More